新宙邦(300037.SZ):公司不直接生產電池
格隆匯2月24日丨新宙邦(300037.SZ)在投資者互動平臺表示,公司不直接生產電池,公司核心業務之一是電池化學品,我司電池化學品主要產品有:鋰離子電池化學品(包括鋰離子電池電解液、添加劑、新型鋰鹽、碳酸酯溶劑)、超級電容器化學品、一次鋰電池化學品、鈉離子電池化學品、固態電池化學材料。下遊市場包括動力電池、儲能電池和消費類電池,應用領域非常廣泛。機器人、無人機等新領域未來市場空間巨大,公司的電池化學品和其他各類產品(電容化學品、半導體化學品、有機氟化學品)也會積極參與到行業發展中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.